Antarctic krill ( Euphausia superba ) oil has been receiving increasing attention due to its nutritional and functional potentials. However, its application as a novel food ingredient has not yet been fully explored. This review summarizes the chemical composition, extraction technologies, potential health benefits, and current applications of krill oil, with the aim of providing suggestions for its exploitation. Krill oil is a unique lipid consisting of diverse lipid classes and is characterized by a high concentration (39.29% to 80.69%) of phospholipids (PLs) associated with eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). It also contains considerable amounts of bioactive minor components such as astaxanthin, sterols, tocopherols, vitamin A, flavonoids, and minerals. The current technologies used in krill oil production are solvent extraction, nonsolvent extraction, super/subcritical fluid extraction, and enzyme‐assisted pretreatment extraction, which all greatly influence the yield and quality of the end‐product. In addition, krill oil has been documented to have various health benefits, including anti‐inflammatory effects, cardiovascular disease (CVD) prevention, women's health, neuroprotection, and anticancer activities. Although krill oil products used for dietary supplements have been commercially available, few studies have attempted to explore the underlying molecular mechanisms to elucidate how exactly the krill oil exerts different biological activities. Further studies should focus on this to improve the development of krill oil products for human consumption.

The purpose of this research was to investigate the chemical profile, nutritional quality, antioxidant and hypolipidemic effects of Mexican chia seed oil (CSO) in vitro. Chemical characterization of CSO indicated the content of α-linolenic acid (63.64% of total fatty acids) to be the highest, followed by linoleic acid (19.84%), and saturated fatty acid (less than 11%). Trilinolenin content (53.44% of total triacylglycerols (TAGs)) was found to be the highest among seven TAGs in CSO. The antioxidant capacity of CSO, evaluated with ABTS^•+ and DPPH^• methods, showed mild antioxidant capacity when compared with Tocopherol and Catechin. In addition, CSO was found to lower triglyceride (TG) and low-density lipoprotein-cholesterol (LDL-C) levels by 25.8% and 72.9%respectively in a HepG2 lipid accumulation model. As CSO exhibits these chemical and biological characteristics, it is a potential resource of essential fatty acids for human use.

The prevalence of obesity has received global attention in recent years, and lipid consumption has been considered as one of the direct reasons for obesity and related diseases. However, increasing evidence has indicated that edible vegetable oils could exert non-negligible physiological benefits in the daily diet, including suppression of appetite, lowering of blood lipids, prevention of adipocyte synthesis, and reduction of inflammatory response. Bioactive phytochemicals in lipids and oils, such as tocopherol, phenolic compounds, and phytosterol, play an important role in these effects according to in vitro and in vivo studies. For these reasons, the present review focusses on minor bioactive components in oil and their anti-obesity effects, aiming to provide a systematic overview of the relationships between these minor components and obesity and related diseases.